Sign in
4

Changes in Ownership

Compass Therapeutics, Inc. Filed Acc 0001171843-25-000825

Options or other derivatives

  • Sr VP, Gen Counsel & Corp Sec acquired 280,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Anderman Jonathan Sr VP, Gen Counsel & Corp Sec 2025-02-11 Grant or award · Stock Option (Right to Buy) +280,000 280,000 D
Loading xslF345X05/ownership.xml…